A new report by the Harvey L. Neiman Health Policy Institute recommends a bundled payment model for breast cancer screening, with the objective of improved patient care and a more efficient use of healthcare resources.
A new report by the Harvey L. Neiman Health Policy Institute recommends a bundled payment model for breast cancer screening, with the objective of improved patient care and a more efficient use of healthcare resources.
The authors of the paper published in the Journal of the American College of Radiology developed a bundled payment model for breast cancer screening using retrospective Medicare claims data and data from a private health system. Bundles were developed with a screening mammography event and included downstream diagnostic breast imaging services during a 364-day episode window.
The model, which includes definitions for alternative screening episodes, methods for calibrating prices, and an examination of risk, found that the utilization of breast services associated with breast cancer screening and diagnosis remained stable over time. Including high-risk patients in the bundled payment model did not significantly influence bundle prices, the researchers report. On the contrary, the choice of services included in the bundle did affect prices. The researchers believe that such a model could help build a practice framework that could reduce variation.
“As the U.S. health care delivery system transitions from [fee-for-service] to value based payments, it’s important that we [radiologists] are at the table to ensure that our patients have access to high quality imaging,” said coauthor Geraldine McGinty, MD, MBA, FACR, vice chair of the American College of Radiology Board of Chancellors and a member of the Neiman Institute’s advisory board in a statement. “Shaping payment policy to support that access is at the core of the ACR’s mission. Bundled payments are seen by policymakers as a vehicle for aligning incentives and in fact the CMS have now imposed mandatory bundling for joint replacement and cardiovascular care.”
She emphasized that their results do not recommend the price for CMS or other payers; rather, their proposal presents a framework that can be used by a clinical practice, in collaboration with payers, to develop a personalized model based on the population they serve.
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations
April 22nd 2024Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Read More